BRAF and mismatch repair cancer syndrome 1: Universal MMR deficiency (dMMR) screening by immunohistochemistry (IHC) for MMR and BRAF V600E proteins in resected tumor samples revealed significant downregulation of the MLH1 and PMS2 proteins, indicating dMMR, while BRAF V600E was negative.